Shoulder Innovations, Inc. announced the appointment of Andrew Hykes, Age 53, to the company's Board of Directors and as a member of the Compensation Committee, effective February 26, 2026. On February 26, 2026, Geoff Pardo notified the Board of Directors (?Board?) of the company that he will resign as a Class I director of the Board, as a member of the Compensation Committee of the Board and as Chair of the Nominating and Corporate Governance Committee of the Board effective immediately. Mr. Hykes is a seasoned medical device executive with more than 25 years of operating experience.
He currently serves as President and Chief Executive Officer of Okami Medical, a privately held medical technology company pioneering novel vascular embolization solutions. He joined Okami Medical following nearly 8 years at Inari Medical, having served most recently as Chief Executive Officer from 2023 until Inari's acquisition by Stryker Corporation in 2025. He also held the roles of Chief Operating Officer and Chief Commercial Officer during his tenure at Inari Medical.
Prior, he served as Vice President of Commercial Operations at Sequent Medical, where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market, before Sequent's acquisition by Terumo Corporation. Earlier in his career, Mr. Hykes spent 11 years at Medtronic where he held multiple roles of increasing responsibility across various business units, including Vice President of Clinical and Regulatory Affairs, Vice President of Marketing, and Director of Investor Relations.
